Cornerstone Therapeutics sales and marketing update

By WIR Staff | Nov 25, 2013 | 8:00 AM GMT

Cornerstone launched Bethkis tobramycin inhalation solution in the U.S. to manage Pseudomonas

Read the full 123 word article

How to gain access

Continue reading with a
two-week free trial.